Finance

Lists
1276:HKG
Jiangsu Hengrui Pharmaceuticals Co Ltd
၄၇.၆၀ HK$
-၀.၈၃%
(-၀.၄၀) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1276...
Open
၄၈.၀၀ HK$
High
၄၉.၃၀ HK$
Low
၄၆.၉၂ HK$
Mkt. cap
ဋေ ၃.၄၆ သ
Avg. vol.
၄.၀၄ သန်း
Volume
၄.၁၆ သန်း
P/E ratio
၃၄.၈၆
52-wk high
၈၄.၅၀ HK$
52-wk low
၄၃.၀၂ HK$
EPS
၁.၃၇ HK$
No. of employees
၂ သောင်း
Open
၄၈.၀၀ HK$
High
၄၉.၃၀ HK$
Low
၄၆.၉၂ HK$
Mkt. cap
ဋေ ၃.၄၆ သ
Avg. vol.
၄.၀၄ သန်း
Volume
၄.၁၆ သန်း
P/E ratio
၃၄.၈၆
52-wk high
၈၄.၅၀ HK$
52-wk low
၄၃.၀၂ HK$
EPS
၁.၃၇ HK$
No. of employees
၂ သောင်း
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၁ နာရီ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂ မိနစ်
Top Growth Stocks With Insider Buying For October 2026
www.marketscreener.com
www.marketscreener.com
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Inter & Co, Inc.(NasdaqGS: INTR) added to S&P Global BMI Index
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၂ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees၂.၀၇ သောင်း
Founded၁၉၇၀
Headquarters-
Sector-
Next call ၈ ရက်အတွင်း
အောက် ၂၇ အင်္ဂါ, ၉:၀၀
Fiscal period
Q3 2026
- / ၀.၃၁ CN¥
Revenue / Est. (CNY)
- / ၉၁၇.၃၇ ဋေ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၇၄၂.၆၉ ဋေ
၈၄၄.၁၃ ဋေ
၈၁၄.၀၆ ဋေ
၇၃၁.၅၀ ဋေ
Cost of goods sold
၁၀၇.၁၀ ဋေ
၁၂၅.၄၁ ဋေ
၁၀၉.၀၉ ဋေ
၁၀၂.၂၄ ဋေ
Cost of revenue
၁၀၇.၁၀ ဋေ
၁၂၅.၄၁ ဋေ
၁၀၉.၀၉ ဋေ
၁၀၂.၂၄ ဋေ
Research and development expenses
၁၇၁.၇၄ ဋေ
၂၀၁.၅၈ ဋေ
၁၆၅.၀၆ ဋေ
၁၈၄.၂၃ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၂၃.၂၉ ဋေ
၃၀၀.၅၃ ဋေ
၂၈၁.၄၂ ဋေ
၂၇၈.၄၂ ဋေ
Operating expense
၄၇၆.၀၀ ဋေ
၅၃၄.၆၆ ဋေ
၄၄၇.၉၇ ဋေ
၄၆၁.၁၃ ဋေ
Total operating expenses
၅၈၃.၁၀ ဋေ
၆၆၀.၀၇ ဋေ
၅၅၇.၀၇ ဋေ
၅၆၃.၃၇ ဋေ
Operating income
၁၅၉.၅၉ ဋေ
၁၈၄.၀၆ ဋေ
၂၅၆.၉၉ ဋေ
၁၆၈.၁၄ ဋေ
Other non operating income
-၁၅.၄၂ ကုဋေ
၁၄.၅၇ ကုဋေ
-၃၄.၅၁ ကုဋေ
၂၄.၃၉ ကုဋေ
EBT including unusual items
၁၃၆.၁၁ ဋေ
၂၂၉.၅၆ ဋေ
၂၅၅.၆၉ ဋေ
၂၃၉.၅၆ ဋေ
EBT excluding unusual items
၁၆၈.၄၆ ဋေ
၁၉၀.၉၆ ဋေ
၂၅၄.၇၃ ဋေ
၁၆၀.၂၈ ဋေ
Income tax expense
၅.၅၅ ကုဋေ
၃၃.၈၉ ကုဋေ
၂၇.၅၉ ကုဋေ
၂၁.၁၃ ကုဋေ
Effective tax rate
၄.၀၈%
၁၄.၇၆%
၁၀.၇၉%
၈.၈၂%
Other operating expenses
-၂၁.၇၃ ကုဋေ
၃၂.၆၈ ကုဋေ
၄.၇၆ သန်း
-၅.၀၉ သန်း
Net income
၁၃၀.၁၁ ဋေ
၁၉၅.၉၉ ဋေ
၂၂၈.၂၃ ဋေ
၂၁၈.၃၂ ဋေ
Net profit margin
၁၇.၅၂%
၂၃.၂၂%
၂၈.၀၄%
၂၉.၈၄%
Earnings per share
၀.၂၀
-
-
-
Interest and investment income
၂၄.၂၁ ကုဋေ
၂၈.၈၇ ကုဋေ
၃၂.၃၀ ကုဋေ
၄.၄၈ သိန်း
Interest expense
-၆.၉၀ သိန်း
-၂.၀၀ သန်း
-၄.၄၈ သိန်း
-၃၂.၃၀ ကုဋေ
Net interest expenses
၂၄.၁၅ ကုဋေ
၂၈.၆၇ ကုဋေ
၃၂.၂၅ ကုဋေ
-၃၂.၂၅ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၇၇.၅၅ ဋေ
၂၀၄.၁၂ ဋေ
၂၇၇.၀၅ ဋေ
၁၉၂.၅၀ ဋေ
Gain or loss from assets sale
၂.၃၁ သန်း
-၄.၀၅ သန်း
-
-၄.၀၆ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ